Volume | 365,894 |
|
|||||
News | - | ||||||
Day High | 5.135 | Low High |
|||||
Day Low | 4.77 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Puma Biotechnology Inc | PBYI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
5.09 | 4.77 | 5.135 | 4.83 | 5.13 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,463 | 365,894 | $ 4.91 | $ 1,794,762 | - | 2.13 - 7.73 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:09:56 | average | 56,109 | $ 4.83 | USD |
Puma Biotechnology Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
232.36M | 48.21M | - | 235.64M | 21.59M | 0.45 | 10.76 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Puma Biotechnology News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PBYI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 5.13 | 5.34 | 4.77 | 5.09 | 277,276 | -0.30 | -5.85% |
1 Month | 5.63 | 6.055 | 4.77 | 5.38 | 326,079 | -0.80 | -14.21% |
3 Months | 4.76 | 7.73 | 4.14 | 5.76 | 604,287 | 0.07 | 1.47% |
6 Months | 2.31 | 7.73 | 2.13 | 5.16 | 453,076 | 2.52 | 109.09% |
1 Year | 2.78 | 7.73 | 2.13 | 4.64 | 312,721 | 2.05 | 73.74% |
3 Years | 10.16 | 11.95 | 1.60 | 4.41 | 387,251 | -5.33 | -52.46% |
5 Years | 34.50 | 35.22 | 1.60 | 8.65 | 676,966 | -29.67 | -86.00% |
Puma Biotechnology Description
Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. |